These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 31960943)

  • 1. Long-term follow-up after cardiac resynchronization therapy-optimization in a real-world setting: A single-center cohort study.
    Korach R; Kahr PC; Ruschitzka F; Steffel J; Flammer AJ; Winnik S
    Cardiol J; 2021; 28(5):728-737. PubMed ID: 31960943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atrioventricular delay programming and the benefit of cardiac resynchronization therapy in MADIT-CRT.
    Brenyo A; Kutyifa V; Moss AJ; Mathias A; Barsheshet A; Pouleur AC; Knappe D; McNitt S; Polonsky B; Huang DT; Solomon SD; Zareba W; Goldenberg I
    Heart Rhythm; 2013 Aug; 10(8):1136-43. PubMed ID: 23712031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of cardiac resynchronization therapy on left atrial reverse remodeling: role of echocardiographic AV delay optimization.
    Malagoli A; Rossi L; Franchi F; Piepoli MF; Malavasi V; Casali E; Modena MG; Villani GQ
    Int J Cardiol; 2013 Aug; 167(4):1456-60. PubMed ID: 22560916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive cardiac resynchronization therapy optimization in the real world.
    Steffel J; Rempel H; Breitenstein A; Schmidt S; Namdar M; Krasniqi N; Holzmeister J; Lüscher TF; Ruschitzka F; Hürlimann D
    Cardiol J; 2014; 21(3):316-24. PubMed ID: 23990194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of cardiac resynchronization therapy optimization inside a heart failure programme: a real-world experience.
    Moulin T; Hamon D; Djouadi K; D'Humières T; Elbaz N; Boukantar M; Zerbib C; Rouffiac S; Dhanjal TS; Ernande L; Derumeaux G; Teiger E; Damy T; Lellouche N
    ESC Heart Fail; 2022 Oct; 9(5):3101-3112. PubMed ID: 35748123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential benefit of optimizing atrioventricular & interventricular delays in patients with cardiac resynchronization therapy.
    Urbanek B; Kaczmarek K; Klimczak A; Ruta J; Chudzik M; Piestrzeniewicz K; Ptaszynski P; Wranicz JK
    Indian J Med Res; 2017 Jul; 146(1):71-77. PubMed ID: 29168462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of different invasive hemodynamic methods for AV delay optimization in patients with cardiac resynchronization therapy: implications for clinical trial design and clinical practice.
    Whinnett ZI; Francis DP; Denis A; Willson K; Pascale P; van Geldorp I; De Guillebon M; Ploux S; Ellenbogen K; Haïssaguerre M; Ritter P; Bordachar P
    Int J Cardiol; 2013 Oct; 168(3):2228-37. PubMed ID: 23481908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Temporal variation in optimal atrioventricular and interventricular delay during cardiac resynchronization therapy.
    Porciani MC; Dondina C; Macioce R; Demarchi G; Cappelli F; Lilli A; Pappone A; Ricciardi G; Colombo PC; Padeletti M; Jelic S; Padeletti L
    J Card Fail; 2006 Dec; 12(9):715-9. PubMed ID: 17174233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biventricular pacing (cardiac resynchronization therapy): an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2005; 5(13):1-60. PubMed ID: 23074464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simultaneous His Bundle and Left Ventricular Pacing for Optimal Cardiac Resynchronization Therapy Delivery: Acute Hemodynamic Assessment by Pressure-Volume Loops.
    Padeletti L; Pieragnoli P; Ricciardi G; Innocenti L; Checchi L; Padeletti M; Michelucci A; Picariello F; Valsecchi S
    Circ Arrhythm Electrophysiol; 2016 May; 9(5):. PubMed ID: 27162032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of synchronous atrioventricular delay optimization on left ventricle flow force angle evaluated by echocardiographic particle image velocimetry.
    Bianchi V; Martiniello AR; Mangual J; Tavoletta V; Pedrizzetti G; Tonti G; Caso VM; Caso P; D'Onofrio A
    J Interv Card Electrophysiol; 2022 Jan; 63(1):1-8. PubMed ID: 33474704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. His-Optimized Cardiac Resynchronization Therapy to Maximize Electrical Resynchronization: A Feasibility Study.
    Vijayaraman P; Herweg B; Ellenbogen KA; Gajek J
    Circ Arrhythm Electrophysiol; 2019 Feb; 12(2):e006934. PubMed ID: 30681348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multipoint left ventricular pacing improves response to cardiac resynchronization therapy with and without pressure-volume loop optimization: comparison of the long-term efficacy of two different programming strategies.
    Ciconte G; Ćalović Ž; McSpadden LC; Ryu K; Mangual J; Caporaso I; Baldi M; Saviano M; Cuko A; Vitale R; Conti M; Giannelli L; Vicedomini G; Santinelli V; Pappone C
    J Interv Card Electrophysiol; 2019 Mar; 54(2):141-149. PubMed ID: 30483980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of mechanical dyssynchrony in cardiac resynchronization therapy.
    Risum N
    Dan Med J; 2014 Dec; 61(12):B4981. PubMed ID: 25441737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. On-treatment comparison between corrective His bundle pacing and biventricular pacing for cardiac resynchronization: A secondary analysis of the His-SYNC Pilot Trial.
    Upadhyay GA; Vijayaraman P; Nayak HM; Verma N; Dandamudi G; Sharma PS; Saleem M; Mandrola J; Genovese D; Oren JW; Subzposh FA; Aziz Z; Beaser A; Shatz D; Besser S; Lang RM; Trohman RG; Knight BP; Tung R;
    Heart Rhythm; 2019 Dec; 16(12):1797-1807. PubMed ID: 31096064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimization of left ventricular pacing site plus multipoint pacing improves remodeling and clinical response to cardiac resynchronization therapy at 1 year.
    Zanon F; Marcantoni L; Baracca E; Pastore G; Lanza D; Fraccaro C; Picariello C; Conte L; Aggio S; Roncon L; Pacetta D; Badie N; Noventa F; Prinzen FW
    Heart Rhythm; 2016 Aug; 13(8):1644-51. PubMed ID: 27450156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Usefulness and Limitations of Impedance Cardiography for Cardiac Resynchronization Therapy Device Optimization.
    Ogawa K; Igarashi M; Nogami A; Yamamoto M; Sugano A; Sekiguchi Y; Aonuma K; Ieda M
    Int Heart J; 2020; 61(5):896-904. PubMed ID: 32999195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of Cardiac Resynchronization Therapy Using Automated Dynamic Optimization and Left Ventricular-only Pacing.
    Gwag HB; Park Y; Lee SS; Kim JS; Park KM; On YK; Park SJ
    J Korean Med Sci; 2019 Jul; 34(27):e187. PubMed ID: 31293111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Longer Left Ventricular Electric Delay Reduces Mitral Regurgitation After Cardiac Resynchronization Therapy: Mechanistic Insights From the SMART-AV Study (SmartDelay Determined AV Optimization: A Comparison to Other AV Delay Methods Used in Cardiac Resynchronization Therapy).
    Chatterjee NA; Gold MR; Waggoner AD; Picard MH; Stein KM; Yu Y; Meyer TE; Wold N; Ellenbogen KA; Singh JP
    Circ Arrhythm Electrophysiol; 2016 Nov; 9(11):. PubMed ID: 27906653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tailored echocardiographic interventricular delay programming further optimizes left ventricular performance after cardiac resynchronization therapy.
    Vanderheyden M; De Backer T; Rivero-Ayerza M; Geelen P; Bartunek J; Verstreken S; De Zutter M; Goethals M
    Heart Rhythm; 2005 Oct; 2(10):1066-72. PubMed ID: 16188583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.